The forecast for spending on pharmaceutical benefits in 2025-26, which is just 8 weeks from finalisation, is $5.6 billion higher than it was four years ago, assuming most of that growth will be offset by rebates. This is not to defend the status quo but to encourage accuracy. …
Updated forecast highlights the real risk of relying on these numbers
May 13, 2026 Latest NewsBioPharmaNews of the Day
Latest Video
New Stories
-
Frustrated minister encourages an early negotiation of new agreements
May 14, 2026 - - Latest News -
Long-term study finds continuing Mounjaro helps maintain weight loss
May 14, 2026 - - Latest News -
GBMA welcomes Budget pathway to increasing biosimilar uptake
May 14, 2026 - - Latest News -
There are a number of reasons to criticise the minister on the PBS, but he is right to be annoyed about this
May 14, 2026 - - Latest News -
Disappointment for diabetes advocates in response to Government budget silence
May 13, 2026 - - Latest News -
Updated forecast highlights the real risk of relying on these numbers
May 13, 2026 - - Latest News -
Baxter and MTAA launch Australian Healthcare Manufacturing Leaders Network
May 13, 2026 - - Latest News